Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I COVID-19 vaccine study for treatment of corona virus infection

Trial Profile

Phase I COVID-19 vaccine study for treatment of corona virus infection

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 14 May 2020

At a glance

  • Drugs Coronavirus vaccine-Medicago (Primary)
  • Indications Coronavirus infections; COVID 2019 infections
  • Focus Adverse reactions
  • Sponsors Medicago
  • Most Recent Events

    • 14 May 2020 According to a Medicago media release, the company will submit an investigational new drug submission with the FDA in the United States to allow for the initiation of human clinical trials this summer.
    • 18 Mar 2020 New trial record
    • 12 Mar 2020 According to a Medicago media release, the company expects to discuss with the appropriate Health Agencies to initiate human trials of the vaccine by summer (July/August) 2020.

Trial Overview

Purpose

This study will investigate COVID-19 vaccine for treatment of corona virus infection.

Diseases Treated

Indication Qualifiers Patient Segments
Coronavirus infections treatment -
COVID 2019 infections treatment -

Subjects

  • Subject Type patients
  • Sex not stated

Trial Details

Organisations

  • Sponsors Medicago
  • Affiliations Medicago

Trial Dates

Other Details

  • Design prospective
  • Phase of Trial Phase I
  • Location USA
  • Focus Adverse reactions

Interventions

Drugs Route Formulation
Coronavirus vaccine-MedicagoPrimary Drug
-
-

Coronavirus vaccine

Coronavirus vaccine

Trial History

Event Date Event Type Comment
14 May 2020 Other trial event According to a Medicago media release, the company will submit an investigational new drug submission with the FDA in the United States to allow for the initiation of human clinical trials this summer. Updated 20 May 2020
18 Mar 2020 New trial record New trial record Updated 18 Mar 2020
12 Mar 2020 Other trial event According to a Medicago media release, the company expects to discuss with the appropriate Health Agencies to initiate human trials of the vaccine by summer (July/August) 2020. Updated 18 Mar 2020

References

  1. Medicago. Medicago announces production of a viable vaccine candidate for COVID-19. Media-Rel 2020;.

    Media Release
  2. Medicago. Medicago Announces Positive Results in Animal Trials for Its Vaccine Candidate Against COVID-19. Media-Rel 2020;.

    Media Release
Back to top